Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

Silvia Grazioli; Maddalena Mauri; Alessandro Crippa; Eleonora Maggioni; Massimo Molteni; Paolo Brambilla; Maria Nobile

doi:10.1016/j.jad.2018.10.100

Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

Silvia Grazioli, Maddalena Mauri, Alessandro Crippa, Eleonora Maggioni, Massimo Molteni, Paolo Brambilla, Maria Nobile

Research output: Contribution to journal › Review article › peer-review

Abstract

BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD.

METHODS: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine.

RESULTS: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found.

LIMITATIONS: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients' medication status and washout period, explored cerebral regions, and neuropsychological tasks.

CONCLUSIONS: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.

Original language	English
Pages (from-to)	100-106
Number of pages	7
Journal	Journal of Affective Disorders
Volume	244
DOIs	https://doi.org/10.1016/j.jad.2018.10.100
Publication status	Published - Feb 1 2019

Access to Document

10.1016/j.jad.2018.10.100

Cite this

Light up ADHD : II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? / Grazioli, Silvia; Mauri, Maddalena; Crippa, Alessandro; Maggioni, Eleonora; Molteni, Massimo ; Brambilla, Paolo ; Nobile, Maria.

In: Journal of Affective Disorders, Vol. 244, 01.02.2019, p. 100-106.

Research output: Contribution to journal › Review article › peer-review

@article{eaede4775e7348b5aa1e893491ce2379,

title = "Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?",

abstract = "BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD.METHODS: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine.RESULTS: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found.LIMITATIONS: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients' medication status and washout period, explored cerebral regions, and neuropsychological tasks.CONCLUSIONS: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.",

author = "Silvia Grazioli and Maddalena Mauri and Alessandro Crippa and Eleonora Maggioni and Massimo Molteni and Paolo Brambilla and Maria Nobile",

year = "2019",

month = feb,

day = "1",

doi = "10.1016/j.jad.2018.10.100",

language = "English",

volume = "244",

pages = "100--106",

journal = "Journal of Affective Disorders",

issn = "0165-0327",

publisher = "Elsevier",

}

TY - JOUR

T1 - Light up ADHD

T2 - II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

AU - Grazioli, Silvia

AU - Mauri, Maddalena

AU - Crippa, Alessandro

AU - Maggioni, Eleonora

AU - Molteni, Massimo

AU - Brambilla, Paolo

AU - Nobile, Maria

PY - 2019/2/1

Y1 - 2019/2/1

N2 - BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD.METHODS: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine.RESULTS: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found.LIMITATIONS: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients' medication status and washout period, explored cerebral regions, and neuropsychological tasks.CONCLUSIONS: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.

AB - BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD.METHODS: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine.RESULTS: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found.LIMITATIONS: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients' medication status and washout period, explored cerebral regions, and neuropsychological tasks.CONCLUSIONS: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.

U2 - 10.1016/j.jad.2018.10.100

DO - 10.1016/j.jad.2018.10.100

M3 - Review article

C2 - 30332620

VL - 244

SP - 100

EP - 106

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -

Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

Abstract

Access to Document

Fingerprint

Cite this